Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia.
作者信息
Pepeler Mehmet Sezgin, Dağdaş Simten, İşleyen Emel, Katayıfçı Gaye, Kılıçarslan Aydan, Özhamam Esra, Adakul Muhammed Talha, Öztürk Fahir, Ceran Funda, Özet Gülsüm
机构信息
University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye
Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine (Intern), Ankara, Türkiye
出版信息
Turk J Haematol. 2024 Dec 2;41(4):288-290. doi: 10.4274/tjh.galenos.2024.2024.0231. Epub 2024 Nov 18.
Abstract
摘要
相似文献
1
Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia.
Turk J Haematol. 2024 Dec 2;41(4):288-290. doi: 10.4274/tjh.galenos.2024.2024.0231. Epub 2024 Nov 18.
2
Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia.
Blood Cells Mol Dis. 2021 May;88:102464. doi: 10.1016/j.bcmd.2020.102464. Epub 2020 Jul 2.
3
Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab.
J Hematol. 2023 Dec;12(6):277-282. doi: 10.14740/jh1195. Epub 2023 Dec 9.
4
Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment.
Acta Haematol. 2021;144(6):683-687. doi: 10.1159/000515257. Epub 2021 Apr 22.
5
Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation.
Case Rep Oncol. 2012 Jan;5(1):110-3. doi: 10.1159/000337022. Epub 2012 Feb 29.
6
Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.
Haematologica. 2009 Feb;94(2):239-48. doi: 10.3324/haematol.13356. Epub 2009 Jan 14.
7
Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease.
Front Immunol. 2023 Jun 23;14:1212007. doi: 10.3389/fimmu.2023.1212007. eCollection 2023.
8
Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2018 Aug;24(8):1765-1770. doi: 10.1016/j.bbmt.2018.04.022. Epub 2018 Apr 21.
9
Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant.
J Clin Apher. 2023 Aug;38(4):495-499. doi: 10.1002/jca.22041. Epub 2023 Jan 26.
10
Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation.
Front Immunol. 2022 Feb 11;13:829670. doi: 10.3389/fimmu.2022.829670. eCollection 2022.
本文引用的文献
1
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.
Am J Hematol. 2023 Apr;98(4):608-619. doi: 10.1002/ajh.26834. Epub 2023 Jan 16.
2
Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics.
Blood Adv. 2022 Apr 26;6(8):2707-2721. doi: 10.1182/bloodadvances.2021006279.
3
Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation.
J Zhejiang Univ Sci B. 2021 Aug 15;22(8):695-700. doi: 10.1631/jzus.B2000532.
4
Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2018 Aug;24(8):1765-1770. doi: 10.1016/j.bbmt.2018.04.022. Epub 2018 Apr 21.
5
Marrow failure: a window into ribosome biology.
Blood. 2014 Oct 30;124(18):2784-92. doi: 10.1182/blood-2014-04-526301. Epub 2014 Sep 18.
6
The genetics of inherited sideroblastic anemias.
Semin Hematol. 2002 Oct;39(4):270-81. doi: 10.1053/shem.2002.35637.
Zotero 插件